Antihistamines in Eosinophilic Esophagitis

PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 10, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions

Eosinophilic Esophagitis

Interventions

DRUG

Famotidine

40 mg tab twice daily by mouth for 12 week duration

DRUG

Loratadine

10 mg tab once daily by mouth for 12 week duration

DRUG

Placebo

Contains no active ingredient

Trial Locations (1)

Mayo Clinic, Jacksonville